DiscoverCanadian Urological Association (CUA)David Kendler | Bone Health Management in Prostate Cancer | Q&A Series
David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

Update: 2022-04-20
Share

Description

Sponsored by Amgen.

David Kendler
Endocrinologist and Clinical Professor
UBC

Disclosures:
Advisory Board: Amgen, Paladin, Biosynt
Speakers Bureau: Amgen
Payment: Amgen, Biosynt, Radius Pharma, Paladin
Grant/Honorarium: Amgen, Biosynt, Radius Pharma, Paladin
Clinical Trial: Radius Pharma
Leadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)

 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

David Kendler